FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity. (Q53037689)
Jump to navigation
Jump to search
scientific article published on 12 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity. |
scientific article published on 12 November 2014 |
Statements
FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity (English)
Brian Ghoshhajra
Christie M Ballantyne
Joshua Lehrer-Graiwer
Parmanand Singh
Amr Abdelbaky
Esad Vucic
Magnus Korsgren
Amos Baruch
Jill Fredrickson
Nick van Bruggen
Meina T Tang
Bjorn Frendeus
Frank Hsieh
Robert S Rosenson
Michael Koren
Eli M Roth
Daniel A Duprez
Zahi A Fayad
Ahmed A Tawakol
12 November 2014